Evidence map›Paper›PMID 37020540›Full record

ReviewFrontiers in immunology2023

Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.

Ni Zhang, Xinchen Tian, Tinghao Yan, Haochen Wang, Dengtian Zhang, Cong Lin, Qingbin Liu, Shulong Jiang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Acetaminophen-induced acute liver injury abrogates the cytosine methylation pathway.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ni ZhangCheeloo College of Medicine, Shandong University, Jinan, China.
Xinchen TianCheeloo College of Medicine, Shandong University, Jinan, China.
Tinghao YanCheeloo College of Medicine, Shandong University, Jinan, China.
Haochen WangClinical Medical Laboratory Center, Jining First People's Hospital, Jining Medical University, Jining, China.
Dengtian ZhangClinical Medical Laboratory Center, Jining First People's Hospital, Jining Medical University, Jining, China.
Cong LinClinical Medical Laboratory Center, Jining First People's Hospital, Jining Medical University, Jining, China.
Qingbin LiuClinical Medical Laboratory Center, Jining First People's Hospital, Jining Medical University, Jining, China.
Shulong JiangCheeloo College of Medicine, Shandong University, Jinan, China.
Jining First People's Hospital · CNShandong University · CNJining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic-associated fatty liver disease (MAFLD) is a chronic liver disease characterized by fatty infiltration of the liver. In recent years, the MAFLD incidence rate has risen and emerged as a serious public health concern. MAFLD typically progresses from the initial hepatocyte steatosis to steatohepatitis and then gradually advances to liver fibrosis, which may ultimately lead to cirrhosis and carcinogenesis. However, the potential evolutionary mechanisms still need to be clarified. Recent studies have shown that nucleotide methylation, which was directly associated with MAFLD's inflammatory grading, lipid synthesis, and oxidative stress, plays a crucial role in the occurrence and progression of MAFLD. In this review, we highlight the regulatory function and associated mechanisms of nucleotide methylation modification in the progress of MAFLD, with a particular emphasis on its regulatory role in the inflammation of MAFLD, including the regulation of inflammation-related immune and metabolic microenvironment. Additionally, we summarize the potential value of nucleotide methylation in the diagnosis and treatment of MAFLD, intending to provide references for the future investigation of MAFLD.

Indexed as

Non-alcoholic Fatty Liver DiseaseHumansInflammationLiver CirrhosisMethylationNucleotidesNucleotidesDNA methylationepitranscriptomicsimmune microenvironmentM 6 A modificationMAFLDmetabolomics

Identifiers

PMID37020540
PMCPMC10067741
OpenAlexW4327978105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.